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As the founding Editor, I was impressed with the way JAD reviewed and managed the publication of paper that I wrote by imagining how the fictional super detective, Sherlock Holmes, might approach finding a cause of the morbidity and mortality associated with the entity we call Alzheimer's disease. In ensuing analysis, I found a new possible culprit, a toxin coded for by a bacterial virus gene (the diphtheria toxin). This suggestion was far from the mainstream but JAD, in accord with its founding principles (and positive comments from its reviewers), published it so that it might function to stimulate a new line of thought and possible research.
We predict that role of this journal will become more important: as analysis of the ever growing genomic database is employed to identify factors associated with Alzheimer's disease, studies of the brain connectome, which are enhancing our understanding of brains structures and function, and applications from potential anti-aging studies such as the recent parabiotic experiments in which older mice began to replace brain, heart, and skeletal muscle cells following surgical procedure which resulted in a shared blood supply with younger mice. In addition, recently developed functional MRI techniques offer both new diagnostic and therapy monitoring capacities. All of these advances will benefit from the enhanced communication and analysis offered by JAD to researchers and clinicians working on Alzheimer's disease.
Given the JAD's performance and steadfast respect for its founding goals to facilitate communication of
